Experts attribute the increase to chronic diseases, which lead to large, long-term costs, the lack of price control on pharmaceutical pricing, and industry consolidation, especially among pharmacies, which eliminates competition and makes it difficult to hold down costs.

Harvard Pilgrim Health Care and Tufts Health Plan's parent company cites rising medical and pharmaceutical costs as the reason for the cuts.